South Carolina Code of Regulations
Chapter 61 - DEPARTMENT OF HEALTH AND ENVIRONMENTAL CONTROL
Subchapter 61-63 - Radioactive Materials (Title A)
Part II - LICENSING OF RADIOACTIVE MATERIAL
Section 61-63.II.RHA 2.10 - Specific Terms and Conditions of Licenses
Current through Register Vol. 48, No. 9, September 27, 2024
2.10.1 Each license issued pursuant to these regulations shall be subject to all the provisions of the Act, and to all rules, regulations, and orders of the Department, now or hereafter in effect.
2.10.2 Specific license transfer requirements.
2.10.3 Each person licensed by the Department pursuant to these regulations shall confine his use and possession of the material licensed to the locations and purposes authorized in the license.
2.10.4 Each specific licensee authorized under 2.7.5 to distribute certain devices to generally licensed persons.
2.10.5 Each licensee shall notify the Department in writing when the licensee decides to permanently discontinue all activities involving materials authorized under the license.
2.10.6 Each general licensee that is required to register by RHA 2.4.2.3.11 of this Part and each specific licensee shall notify the Department, in writing, immediately following the filing of a voluntary or involuntary petition for bankruptcy under any Chapter of Title 11 (Bankruptcy) of the United States Code by or against:
2.10.7 Security requirements for portable gauges.
2.10.8 Each licensee preparing technetium-99m radiopharmaceuticals from molybdenum-99/technetium-99m generators or rubidium-82 from strontium-82/rubidium-82 generators shall test the generator eluates for molybdenum-99 breakthrough or strontium-82 and strontium-85 contamination, respectively, in accordance with RHA 4.38. The licensee shall record the results of each test and retain each record for 3 years after the record is made. The licensee shall report the results of any test that exceeds the permissible concentration listed in 4.38.1 of this chapter at the time of generator elution, in accordance with RHA 4.120 of this chapter.
2.10.9.1 Authorization under Part 2 of this Regulation to produce Positron Emission Tomography (PET) radioactive drugs for noncommercial transfer to medical use licensees in its consortium does not relieve the licensee from complying with applicable FDA, other Federal, and State requirements governing radioactive drugs.
2.10.9.2 Each licensee authorized under Part 2 of this Regulation to produce PET radioactive drugs for noncommercial transfer to medical use licensees in its consortium shall:
2.10.9.3 A licensee that is a pharmacy authorized under Part 2 of this Regulation to produce PET radioactive drugs for noncommercial transfer to medical use licensees in its consortium shall require that any individual that prepares PET radioactive drugs shall be:
2.10.9.4 A pharmacy, authorized under Part 2 of this Regulation to produce PET radioactive drugs for noncommercial transfer to medical use licensees in its consortium that allows an individual to work as an authorized nuclear pharmacist, shall meet the requirements of Part 2 of this Regulation.
2.10.10 Conditions of licenses.